SARS CoV-2 infection among patients using immunomodulatory therapies | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Letter

SARS CoV-2 infection among patients using immunomodulatory therapies

Online download statistics by month:

Online download statistics by month: August 2020 to May 2023

	Abstract	Full	Pdf
Aug 2020	1020	996	318
Sep 2020	390	341	115
Oct 2020	172	182	89
Nov 2020	120	115	61
Dec 2020	126	112	48
Jan 2021	542	529	148
Feb 2021	351	340	181
Mar 2021	231	220	126
Apr 2021	182	167	90
May 2021	137	130	95
Jun 2021	109	105	63
Jul 2021	130	128	75
Aug 2021	112	112	77
Sep 2021	90	83	62
Oct 2021	95	87	68
Nov 2021	74	69	43
Dec 2021	86	79	43
Jan 2022	73	69	49
Feb 2022	52	50	29
Mar 2022	59	60	30
Apr 2022	530	525	43
May 2022	833	830	40
Jun 2022	643	642	41
Jul 2022	147	142	9
Aug 2022	61	60	25
Sep 2022	66	63	34
Oct 2022	45	43	15
Nov 2022	50	46	14
Dec 2022	38	38	18
Jan 2023	58	53	29
Feb 2023	64	62	36
Mar 2023	49	47	25
Apr 2023	80	10	8
May 2023	130	0	0
Total	6945	6535	2147